1. Herb-Partitioned Moxibustion and the miRNAs Related to Crohn’s Disease: A Study Based on Rat Models
   Kai Wei et al, 2015, Evidence-Based Complementary and Alternative Medicine CrossRef
2. Identification of a Novel lincRNA-p21-miR-181b-PTEN Signaling Cascade in Liver Fibrosis
   Fujun Yu et al, 2016, Mediators of Inflammation CrossRef
3. miR-375 and miR-205 Regulate the Invasion and Migration of Laryngeal Squamous Cell Carcinoma Synergistically via AKT-Mediated EMT
   Bin Wang et al, 2016, BioMed Research International CrossRef
4. A microRNA signature of response to erlotinib is descriptive of TGFβ behaviour in NSCLC
   Madeline Krentz Gober et al, 2017, Sci Rep CrossRef
5. Down-regulation of miR-489 contributes into NSCLC cell invasion through targeting SUZ12
   Zongtao Xie et al, 2015, Tumor Biol. CrossRef
6. MicroRNA (miR)-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma
   J. Cañueto et al, 2017, Br J Dermatol CrossRef
7. The microRNA-635 suppresses tumorigenesis in non-small cell lung cancer
   Yan Zhang et al, 2016, Biomedicine & Pharmacotherapy CrossRef
8. Four PTEN-targeting co-expressed miRNAs and ACTN4- targeting miR-548b are independent prognostic biomarkers in human squamous cell carcinoma of the oral tongue
   Ilyes Berania et al, 2017, Int. J. Cancer CrossRef
9. MiR-205 promotes proliferation, migration and invasion of nasopharyngeal carcinoma cells by activation of AKT signalling
   Yanjiao Mao et al, 2016, J Int Med Res CrossRef
10. microRNA-205 acts as a tumor suppressor and directly targets YAP1 in glioma
    Tao Ji et al, 2017 CrossRef
11. Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance
    Duncan Ayers et al, 2017, Genes CrossRef
12. Analysis of MicroRNA Expression Profile Identifies Novel Biomarkers for Non-small Cell Lung Cancer
    Chi Xu et al, 2015, Tumori Journal CrossRef
13. Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs
    Bernhard Biersack, 2017, Non-coding RNA Research CrossRef
14. Inhibition of miR-24 suppresses malignancy of human non-small cell lung cancer cells by targeting WWOX in vitro and in vivo
    Xue-hai Wang et al, 2018, Thorac Cancer CrossRef
15. Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals
    Wei Zhai et al, 2018, Mol Cancer CrossRef
16. MicroRNA Regulation of Energy Metabolism to Induce Chemoresistance in Cancers
    Jin Ye et al, 2018, Technol Cancer Res Treat CrossRef
17. Expression and clinical significance of miR-139-5p in non-small cell lung cancer
    You Yong-hao et al, 2019, J Int Med Res CrossRef
18. Involvement of the Dysregulation of miR-23b-3p, miR-195-5p, miR-656-5p, and miR-340-5p in Trastuzumab Resistance of HER2-Positive Breast Cancer Cells and System Biology Approach to Predict Their Targets Involved in Resistance
    Zohreh Rezaei et al, 2019, DNA and Cell Biology CrossRef
19. Mechanisms of PTEN loss in cancer: It's all about diversity.
    Virginia Álvarez-Garcia et al, 2019, Semin Cancer Biol CrossRef
20. The role and mechanisms of action of microRNAs in cancer drug resistance
    Wengong Si et al, 2019, Clin Epigenet CrossRef
21. Screening of acetaminophen-induced alterations in epithelial-to-mesenchymal transition-related expression of microRNAs in a model of stem-like triple-negative breast cancer cells: The possible functional impacts
    Elham Afshar et al, 2019, Gene CrossRef
22. The Roles of MicroRNA in Lung Cancer
    Kuan-Li Wu et al, 2019, IJMS CrossRef
23. Downregulation of COMMD1 by miR-205 promotes a positive feedback loop for amplifying inflammatory- and stemness-associated properties of cancer cells
    D-W Yeh et al, 2016, Cell Death Differ CrossRef
24. MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2
    Zhenshun Cheng et al, 2014, Exp Mol Med CrossRef
25. MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma
    Natalia García-Sancha et al, 2019, IJMS CrossRef
26. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells
    Pei Zhang et al, 2019, Gene: X CrossRef
27. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells
    Pei Zhang et al, 2019, Gene CrossRef
28. miRNAs in lung cancer: A link to aging
    Anna Zagryazhskaya et al, 2014, Ageing Research Reviews CrossRef
29. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
    Mao Ouyang et al, 2014, PLoS ONE CrossRef
30. MicroRNA-152 targets ADAM17 to suppress NSCLC progression
    Yunshu Su et al, 2014 CrossRef
31. PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around
    Anastasios Gkountakos et al, 2019, Cancers CrossRef
32. miR-195 inhibits the growth and metastasis of NSCLC cells by targeting IGF1R
    Xiaoli Wang et al, 2014, Tumor Biol. CrossRef
33. MicroRNA-27b suppresses growth and invasion of NSCLC cells by targeting Sp1
    Jun Jiang et al, 2014, Tumor Biol. CrossRef
34. MicroRNAs: a new key in lung cancer
    Yunlong Zhang et al, 2014, Cancer Chemother Pharmacol CrossRef
35. MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges
    Huiyin Lan et al, 2015, BioMed Research International CrossRef
36. MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.
    Paul Zarogoulidis et al, 0 CrossRef
37. MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus
    Renata Hezova et al, 2016, Tumor Biol. CrossRef
38. Prognostic impact of a 3-MicroRNA signature in cytological samples of small cell lung cancer
    Giuseppe Mancuso et al, 2016, Cancer Cytopathology CrossRef
39. miR-3940-5p Functions as a Tumor Suppressor in Non–Small Cell Lung Cancer Cells by Targeting Cyclin D1 and Ubiquitin Specific Peptidase-28
    Kewei Ren et al, 2017, Translational Oncology CrossRef
40. Exosomal miRs in Lung Cancer: A Mathematical Model
    Xiulan Lai et al, 2016, PLoS ONE CrossRef
41. Phosphatases and solid tumors: focus on glioblastoma initiation, progression and recurrences
    Matthias Dedobbeleer et al, 2017 CrossRef
42. MicroRNAs in non-small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential.
    Hannah Petrek et al, 2019, Pharmacol Res Perspect CrossRef
43. Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance
    Chunyu Li et al, 2017, Oncotarget CrossRef
44. MiR-205 as a promising biomarker in the diagnosis and prognosis of lung cancer
    Jing-Hua Li et al, 2017, Oncotarget CrossRef
45. Advantages of Restoring miR-205-3p Expression for Better Prognosis of Gastric Cancer via Prevention of Epithelial-mesenchymal Transition
    Zhen Zhang et al, 2020, J Gastric Cancer CrossRef
46. miRNA‑328 overexpression confers cisplatin resistance in non‑small cell lung cancer via targeting of PTEN
    Chunmei Wang et al, 2018, Mol Med Report CrossRef
47. The impact of exogenous CO releasing molecule CORM‑2 on inflammation and signaling of orthotopic lung cancer
    Li Shao et al, 2018, Oncol Lett CrossRef
48. MicroRNA‑205 is downregulated in hepatocellular carcinoma and inhibits cell growth and metastasis via directly targeting vascular endothelial growth factor A
    Xuya Zhao et al, 2018, Oncol Lett CrossRef
49. miR-205: A Potential Biomedicine for Cancer Therapy
    Neeraj Chauhan et al, 2020, Cells CrossRef
50. Deregulated microRNAs Are Associated with Patient Survival and Predicted to Target Genes That Modulate Lung Cancer Signaling Pathways
    Cristiano P. Souza et al, 2020, Cancers CrossRef
51. miR-152/TNS1 axis inhibits non-small cell lung cancer progression through Akt/mTOR/RhoA pathway
    Jinjin Duan et al, 2021 CrossRef
52. Flavonoid display ability to target microRNAs in cancer pathogenesis
    Shilpi Singh et al, 2021, Biochemical Pharmacology CrossRef
53. Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers
    Asal Jalal Abadi et al, 2021, Biomolecules CrossRef
54. Exosomes Derived From Macrophages Enhance Aerobic Glycolysis and Chemoresistance in Lung Cancer by Stabilizing c-Myc via the Inhibition of NEDD4L.
    Huan Wang et al, 2020, Front Cell Dev Biol CrossRef
55. Inhibition Sequence of miR-205 Hinders the Cell Proliferation and Migration of Lung Cancer Cells by Regulating PETN-Mediated PI3K/AKT Signal Pathway
    Huizhen Zhu et al, 2021, Mol Biotechnol CrossRef
56. MicroRNA Therapeutics in Cancer: Current Advances and Challenges.
    Soha Reda El Sayed et al, 2021, Cancers (Basel) CrossRef
57. Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1
    Yan Zhao et al, 2021, Aging CrossRef
58. miR-205 Inhibits Neuroblastoma Growth by Targeting cAMP-Responsive Element-Binding Protein 1
    Shu Chen et al, 2018, oncol res CrossRef
59. Hsa‐miR‐335 enhances cell migration and invasion in lung adenocarcinoma through targeting Copine‐1
    Yang Wang et al, 2021, MedComm CrossRef
60. The Roles of microRNAs in Cancer Multidrug Resistance
    Lucia Pavlíková et al, 2022, Cancers CrossRef
61. MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer?
    Alessandra Cinque et al, 2022, IJMS CrossRef
62. MicroRNAs: Key Regulators in Lung Cancer
    Younes El Founini et al, 2021, MIRNA CrossRef
63. null
    DKV Prasad et al, 2022 CrossRef
64. miRNAs are now starring in “ No Time to Die : Overcoming the chemoresistance in cancer”
    Anmol Bhatia et al, 2022, IUBMB Life CrossRef
65. A Study of miRNAs as Cornerstone in Lung Cancer Pathogenesis and Therapeutic Resistance: A Focus on Signaling Pathways Interplay
    Ahmed S. Doghish et al, 2022, Pathology - Research and Practice CrossRef
66. microRNA-205 in prostate cancer: Overview to clinical translation
    Neeraj Chauhan et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
67. Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment
    Atqiya Fariha et al, 2022, Heliyon CrossRef
68. null
    Oxana V. Klimenko et al, 2022 CrossRef
69. null
    Maksat Babayev et al, 2022 CrossRef
70. Endothelial plasticity across PTEN and Hippo pathways: A complex hormetic rheostat modulated by extracellular vesicles
    Elizabeth Orozco-García et al, 2023, Translational Oncology CrossRef
71. microRNA-660 Enhances Cisplatin Sensitivity via Decreasing SATB2 Expression in Lung Adenocarcinoma
    Ziyao Wang et al, 2023, Genes CrossRef
72. From resistance to resilience: Uncovering chemotherapeutic resistance mechanisms; insights from established models
    Nourhan M. Abdelmaksoud et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef